A Next Generation Multiscale View of Inborn Errors of Metabolism.

Inborn errors of metabolism (IEM) are not unlike common diseases. They often present as a spectrum of disease phenotypes that correlates poorly with the severity of the disease-causing mutations. This greatly impacts patient care and reveals fundamental gaps in our knowledge of disease modifying biology. Systems biology approaches that integrate multi-omics data into molecular networks have significantly improved our understanding of complex diseases. Similar approaches to study IEM are rare despite their complex nature. We highlight that existing common disease-derived datasets and networks can be repurposed to generate novel mechanistic insight in IEM and potentially identify candidate modifiers. While understanding disease pathophysiology will advance the IEM field, the ultimate goal should be to understand per individual how their phenotype emerges given their primary mutation on the background of their whole genome, not unlike personalized medicine. We foresee that panomics and network strategies combined with recent experimental innovations will facilitate this.

[1]  M. Serlie,et al.  Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. , 2013, Cell metabolism.

[2]  D. Jain,et al.  Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis. , 2012, Blood.

[3]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[4]  E. Bézard,et al.  Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration , 2012, Proceedings of the National Academy of Sciences.

[5]  E. Lander,et al.  Development and Applications of CRISPR-Cas 9 for Genome Engineering , 2015 .

[6]  E. Schadt Molecular networks as sensors and drivers of common human diseases , 2009, Nature.

[7]  Charles F. Bearden,et al.  A Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease Risk , 2013, Cell.

[8]  F. España,et al.  Characterization of Variants in the Glucosylceramide Synthase Gene and their Association with Type 1 Gaucher Disease Severity , 2013, Human mutation.

[9]  A. Lusis,et al.  Systems genetics approaches to understand complex traits , 2013, Nature Reviews Genetics.

[10]  Taoyong Chen,et al.  Late Endosome/Lysosome-Localized Rab7b Suppresses TLR9-Initiated Proinflammatory Cytokine and Type I IFN Production in Macrophages1 , 2009, The Journal of Immunology.

[11]  Martin Lindner,et al.  Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. , 2003, Pediatrics.

[12]  C R Scriver,et al.  Monogenic traits are not simple: lessons from phenylketonuria. , 1999, Trends in genetics : TIG.

[13]  F. Baas,et al.  Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia. , 2014, Human molecular genetics.

[14]  I. Macaulay,et al.  Single Cell Genomics: Advances and Future Perspectives , 2014, PLoS genetics.

[15]  Eric E. Schadt,et al.  Moving toward a system genetics view of disease , 2007, Mammalian Genome.

[16]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[17]  Joshua L. Deignan,et al.  Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. , 2012, Molecular genetics and metabolism.

[18]  Radu Dobrin,et al.  Pparγ2 Is a Key Driver of Longevity in the Mouse , 2009, PLoS genetics.

[19]  Rachel B. Brem,et al.  Stitching together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation , 2012, PLoS biology.

[20]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[21]  Robert W. Williams,et al.  Systems Genetics of Metabolism: The Use of the BXD Murine Reference Panel for Multiscalar Integration of Traits , 2012, Cell.

[22]  Zachary A. King,et al.  Constraint-based models predict metabolic and associated cellular functions , 2014, Nature Reviews Genetics.

[23]  E R McCabe,et al.  Consequences of complexity within biological networks: robustness and health, or vulnerability and disease. , 2001, Molecular genetics and metabolism.

[24]  Xia Yang,et al.  Integrating pathway analysis and genetics of gene expression for genome-wide association studies. , 2010, American journal of human genetics.

[25]  R. Fitzgerald,et al.  The '–omics' revolution and oesophageal adenocarcinoma , 2014, Nature Reviews Gastroenterology &Hepatology.

[26]  Diego di Bernardo,et al.  A Genome-Scale Modeling Approach to Study Inborn Errors of Liver Metabolism: Toward an In Silico Patient , 2013, J. Comput. Biol..

[27]  Judy H. Cho,et al.  Genome‐wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation , 2012, American journal of hematology.

[28]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[29]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[30]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[31]  C. Argmann,et al.  Lysosomal Stress in Obese Adipose Tissue Macrophages Contributes to MITF-Dependent Gpnmb Induction , 2014, Diabetes.

[32]  Shane J. Neph,et al.  Circuitry and Dynamics of Human Transcription Factor Regulatory Networks , 2012, Cell.

[33]  G. Cutting Modifier genes in Mendelian disorders: the example of cystic fibrosis , 2010, Annals of the New York Academy of Sciences.

[34]  S. Horvath,et al.  Variations in DNA elucidate molecular networks that cause disease , 2008, Nature.

[35]  E. McCabe,et al.  Modifier genes convert "simple" Mendelian disorders to complex traits. , 2000, Molecular genetics and metabolism.

[36]  Rachel B. Brem,et al.  Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks , 2008, Nature Genetics.

[37]  B. Wilcken,et al.  Screening newborns for inborn errors of metabolism by tandem mass spectrometry. , 2003, The New England journal of medicine.

[38]  S. Dimauro,et al.  Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia , 2013, Proceedings of the National Academy of Sciences.

[39]  N. Novère Quantitative and logic modelling of molecular and gene networks , 2015, Nature Reviews Genetics.

[40]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[41]  Shailesh V. Date,et al.  A Probabilistic Functional Network of Yeast Genes , 2004, Science.

[42]  E. Génin,et al.  Identifying modifier genes of monogenic disease: strategies and difficulties , 2008, Human Genetics.

[43]  M. Ritchie,et al.  Methods of integrating data to uncover genotype–phenotype interactions , 2015, Nature Reviews Genetics.

[44]  C. Argmann,et al.  Impaired amino acid metabolism contributes to fasting-induced hypoglycemia in fatty acid oxidation defects. , 2013, Human molecular genetics.

[45]  D. Kurtz,et al.  Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Auwerx,et al.  Mouse phenogenomics: the fast track to "systems metabolism". , 2005, Cell metabolism.

[47]  A. Schapira,et al.  Glucocerebrosidase mutations and the pathogenesis of Parkinson disease , 2013, Annals of medicine.

[48]  John P. Overington,et al.  An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.

[49]  George A. Truskey,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014, Nature Medicine.

[50]  Ronan M. T. Fleming,et al.  A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.

[51]  S. O’Rahilly,et al.  Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity , 2007, Diabetes.

[52]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[53]  Evan G. Williams,et al.  Multilayered Genetic and Omics Dissection of Mitochondrial Activity in a Mouse Reference Population , 2014, Cell.

[54]  J. Schuurs-Hoeijmakers,et al.  Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness , 2012, Nature Genetics.

[55]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[56]  Robert W. Williams,et al.  An informatics approach to systems neurogenetics. , 2007, Methods in molecular biology.

[57]  I Knudsen,et al.  Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. , 2001, American journal of human genetics.

[58]  E. Ruppin,et al.  Predicting metabolic biomarkers of human inborn errors of metabolism , 2009, Molecular systems biology.

[59]  H. Kacser,et al.  The molecular basis of dominance. , 1981, Genetics.

[60]  Adam D. Kennedy,et al.  Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism , 2015, Journal of Inherited Metabolic Disease.

[61]  Hongyu Zhao,et al.  Disease-drug pairs revealed by computational genomic connectivity mapping on GBA1 deficient, Gaucher disease mice , 2012, Biochemical and Biophysical Research Communications.

[62]  Jun Zhu,et al.  Increasing the Power to Detect Causal Associations by Combining Genotypic and Expression Data in Segregating Populations , 2007, PLoS Comput. Biol..

[63]  H. Lehrach,et al.  A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.

[64]  David J. Arenillas,et al.  A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease , 2015, Nature Neuroscience.

[65]  E R McCabe,et al.  Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. , 2000, American journal of human genetics.

[66]  Yudong D. He,et al.  Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers , 2012, Molecular systems biology.

[67]  H. Vernon Inborn Errors of Metabolism: Advances in Diagnosis and Therapy. , 2015, JAMA pediatrics.

[68]  Nicola Brunetti-Pierri,et al.  Inborn errors of metabolism: the flux from Mendelian to complex diseases , 2006, Nature Reviews Genetics.

[69]  G. Lettre The search for genetic modifiers of disease severity in the β-hemoglobinopathies. , 2012, Cold Spring Harbor perspectives in medicine.

[70]  H. Stefánsson,et al.  Genetics of gene expression and its effect on disease , 2008, Nature.

[71]  V. Mootha,et al.  Targeted exome sequencing of suspected mitochondrial disorders , 2013, Neurology.

[72]  A E Garrod,et al.  The incidence of alkaptonuria: a study in chemical individuality. 1902. , 1996, Molecular medicine.

[73]  J. Castle,et al.  An integrative genomics approach to infer causal associations between gene expression and disease , 2005, Nature Genetics.

[74]  J. Haldane The relative importance of principal and modifying genes in determining some human diseases , 1941 .

[75]  Hongyu Zhao,et al.  Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage , 2010, Proceedings of the National Academy of Sciences.

[76]  Réka Albert,et al.  Boolean modeling: a logic‐based dynamic approach for understanding signaling and regulatory networks and for making useful predictions , 2014, Wiley interdisciplinary reviews. Systems biology and medicine.

[77]  Justin Guinney,et al.  Predictive Genes in Adjacent Normal Tissue Are Preferentially Altered by sCNV during Tumorigenesis in Liver Cancer and May Rate Limiting , 2011, PloS one.

[78]  D. Thorburn,et al.  Minimum birth prevalence of mitochondrial respiratory chain disorders in children. , 2003, Brain : a journal of neurology.

[79]  M. Langeveld,et al.  Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice , 2009, Hepatology.

[80]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[81]  A. Garrod The Incidence of Alkaptonuria: A study in Chemical Individuality , 1996, Nutrition reviews.

[82]  N LeNovère Quantitative and logic modelling of molecular and gene networks. , 2015 .

[83]  Neema Jamshidi,et al.  Systems biology of SNPs , 2006, Molecular systems biology.

[84]  Stephen H. Friend,et al.  Clues from the resilient , 2014, Science.

[85]  Gang Wang,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014 .

[86]  Rui Chang,et al.  Causal Inference in Biology Networks with Integrated Belief Propagation , 2014, Pacific Symposium on Biocomputing.

[87]  Marni J. Falk,et al.  Primary Respiratory Chain Disease Causes Tissue-Specific Dysregulation of the Global Transcriptome and Nutrient-Sensing Signaling Network , 2013, PloS one.

[88]  Peter K. Sorger,et al.  Logic-Based Models for the Analysis of Cell Signaling Networks† , 2010, Biochemistry.

[89]  Joshua D. Campbell,et al.  Integrative Analysis of DNA Methylation and Gene Expression Data Identifies EPAS1 as a Key Regulator of COPD , 2015, PLoS genetics.

[90]  S. Ferdinandusse,et al.  Heimler Syndrome Is Caused by Hypomorphic Mutations in the Peroxisome-Biogenesis Genes PEX1 and PEX6 , 2015, American journal of human genetics.

[91]  Tao Xie,et al.  Inferring causal genomic alterations in breast cancer using gene expression data , 2011, BMC Systems Biology.

[92]  Eric E. Schadt,et al.  Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders , 2014, Front. Pharmacol..

[93]  Edward R B McCabe,et al.  Targeted disruption of glycerol kinase gene in mice: expression analysis in liver shows alterations in network partners related to glycerol kinase activity. , 2006, Human molecular genetics.

[94]  M. Schilsky,et al.  Genetic Modifiers of Liver Injury in Hereditary Liver Disease , 2011, Seminars in liver disease.

[95]  J. Lupski,et al.  Clan Genomics and the Complex Architecture of Human Disease , 2011, Cell.

[96]  Shinya Yamanaka,et al.  iPS cells: a game changer for future medicine , 2014, The EMBO journal.

[97]  H. Baris,et al.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history. , 2014, Pediatric endocrinology reviews : PER.

[98]  M. Gerstein,et al.  A Bayesian Networks Approach for Predicting Protein-Protein Interactions from Genomic Data , 2003, Science.

[99]  S. Gallati The Application of Clinical Genetics Dovepress Disease-modifying Genes and Monogenic Disorders: Experience in Cystic Fibrosis , 2022 .

[100]  A. Arnold,et al.  Tissue-specific expression and regulation of sexually dimorphic genes in mice. , 2006, Genome research.

[101]  A. Suomalainen,et al.  Next‐generation sequencing for mitochondrial disorders , 2014, British journal of pharmacology.

[102]  A. Rudensky,et al.  The lysosomal cysteine proteases in MHC class II antigen presentation , 2005, Immunological reviews.

[103]  T. Taddei,et al.  Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism. , 2013, Critical reviews in oncogenesis.

[104]  P. Mistry,et al.  Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy. , 2002, Molecular genetics and metabolism.

[105]  Marni J. Falk,et al.  Integrated transcriptome analysis across mitochondrial disease etiologies and tissues improves understanding of common cellular adaptations to respiratory chain dysfunction. , 2014, The international journal of biochemistry & cell biology.

[106]  B. Kollerits,et al.  Maternal ABCA1 genotype is associated with severity of Smith–Lemli–Opitz syndrome and with viability of patients homozygous for null mutations , 2012, European Journal of Human Genetics.

[107]  J. Zhu,et al.  An integrative genomics approach to the reconstruction of gene networks in segregating populations , 2004, Cytogenetic and Genome Research.